As we honor Asian American and Pacific Islander heritage, we proudly recognize and appreciate the invaluable contributions of our AAPI staff at Velocity Clinical Research. Their diverse perspectives, talents, and dedication enrich our workplace and strengthen our mission to improve healthcare for all. Let's unite in celebrating the vibrant cultures and achievements of the AAPI community throughout May and beyond. #AAPIHeritageMonth #VelocityCARES
Velocity Clinical Research, Inc.
Biotechnology Research
Durham, North Carolina 19,264 followers
Delivering high-quality clinical trial data and patient care with unprecedented efficiency.
About us
Velocity is the world’s leading organization of fully integrated clinical research sites. With 90 sites and more than 220 investigators, Velocity partners with pharmaceutical and biotechnology companies to research new drugs, medical devices, diagnostics, and combination products that could improve human health and wellbeing. Velocity offers unified research site solutions to efficiently provide the right patients, investigators, and research staff for clinical trials across the U.S. and Europe. The company also operates a technology hub in India, where it is unlocking a new era in clinical research by developing innovative systems to leverage expansive site, patient, and historical performance data. To learn more about how Velocity delivers high-quality data, exemplary patient care, and unprecedented efficiency for clinical trials at any scale, visit VelocityClinical.com.
- Website
-
https://velocityclinical.com
External link for Velocity Clinical Research, Inc.
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Durham, North Carolina
- Type
- Privately Held
- Founded
- 2018
- Specialties
- Clinical trials, Patient Recruitment, Vaccine Research, Pharmaceutical Research, Clinical Research, Vaccines, Neurology, Pediatrics, NASH, Infectious Disease, Dermatology, Women's Health, Gastroenterology, Alllergy, Medical Devices, Research Sites, Principal Investigators, and Drug Development
Locations
Employees at Velocity Clinical Research, Inc.
Updates
-
Velocity recently gathered key employees to discuss crucial issues in diversity, equity, and inclusion (DEI) within clinical trials. Now, we're thrilled to share our insights with you! Watch our diverse panel, including medical professionals, community liaisons, and former trial participants, as they delve into practical strategies to foster trust and connection with local communities. Read the full article and watch the video below to learn: 1️⃣ Tips for building trust through in-person connections 2️⃣ Strategies for forging meaningful partnerships 3️⃣ The power of showcasing personal success stories 4️⃣ Sensitivity to patient populations, especially those with stigmatized conditions 5️⃣ Importance of focusing on local details 6️⃣ Effective local marketing and branding techniques https://lnkd.in/gtNK5-Py #ClinicalTrials #CommunityEngagement #DEI #VelocityCARES Featuring: Nadege Gunn, MD, CPI, Brandi A. Lang, Jonatan Garcia, MPH, Joseph Henderson, Kelsey Niehauser, and more!
-
To celebrate the upcoming Clinical Trials Day and the 'Trailblazers Among Us' theme, Paul Evans, President and CEO of Velocity, and Victoria DiBiaso, Head, Patient Informed Development & Health Value Translation at Sanofi, have coauthored this article. In the post, they review several of the opportunities and challenges inherent in shaping a better future for clinical research. Read now: https://lnkd.in/gjk_BJky
Blazing a Trail in Clinical Research—the first of two blogs in a collaborative series written by Vicky DiBiaso, Head, Patient Informed Development & Health Value Translation, Sanofi, and Paul Evans, President and CEO, Velocity Clinical Research, Inc.—reviews some aspects that are reshaping the industry landscape as we blaze a trail into the future: 1️⃣ As AI becomes more present in our lives, how can it help clinical research? 2️⃣ How do we really move the needle on diversity? 3️⃣ Change places a constantly evolving demand on clinical research professionals. We are grateful for their thought leadership! Please read and share your thoughts in the comments below > https://bit.ly/4aQooMC #ClinicalTrialsDay #CTD2024 #ClinicalResearch #ClinicalTrials #AI #ArtificialIntelligence #WorkforceDevelopment #DCTs #DecentralizedClinicalTrials #TrailblazersAmongUs
-
-
Patient Experience Week is a time to celebrate and recognize the importance of patient-centered care. Clinical research plays an important part in shaping patient experience by providing the opportunity to participate in cutting-edge medical studies and treatments. At Velocity Clinical Research, we prioritize the needs and experiences of our patients and strive to create a welcoming and inclusive environment for all. We believe that by prioritizing patient-centered care in clinical research, we can improve healthcare outcomes and positively impact the lives of individuals around the world. #PatientExperienceWeek #PatientCenteredCare #ClinicalResearch
-
-
Henrik Watz, MD; Anne-Marie Kirsten, MD, Principal Investigators at Velocity Grosshansdorf; and Andrea Ludwig-Sengpiel, PI at Velocity Luebeck, co-authored the manuscript of results for a recent COPD inhaler combination clinical trial. Dr. Watz will present their findings at #ATS2024 in #SanDiego next month.
-
-
Shishir Khetan, MD, is a Principal Investigator and Senior Medical Director at Velocity. He’s also a leading expert for the Vaccine CARE Council. But as he explains in this video, he’s excited about the opportunities the CARE Council model is creating for investigators, even beyond vaccines. Through expert knowledge exchange — including mentoring and training opportunities provided by leading PIs and domain experts — CARE Councils give Velocity sites a path to supporting more disease-specific trials at a high level. #CARECouncils #ClinicalTrials
-
During World Immunization Week, we are so proud to contribute to the next generation of life-saving vaccines that could support longer, healthier lives worldwide. Learn more about the World Health Organization campaign this week: https://buff.ly/49ymcJd #WorldImmunizationWeek2024 #VaccinesSaveLives #ClinicalResearch
-
-
Last week, Velocity’s Waco site hosted the sixth semi-annual MASH Bash — a liver education series featuring speakers like Nadege Gunn, MD, CPI, Velocity PI, Senior Scientific Advisor, and Co-Chair of Velocity’s MASH CARE Council; Jonatan Garcia, MPH, Community Liaison; and Apurva Modi, MD, MS, MHSc of Baylor Scott & White Liver Consultants of Texas. With more than 150 guests representing community providers from across 15 different specialties, the event was a major success, thanks in part to many leading companies. Platinum Sponsors: Gilead Sciences Perspectum Ltd Silver Sponsors: Aligos Therapeutics Akero Therapeutics Corcept Therapeutics Madrigal Pharmaceuticals AcariaHealth Specialty Pharmacy Supporting Sponsors: Salix Pharmaceuticals 89bio ModifyHealth
-
-
-
-
-
+5
-
-
Did you know? The liver is an unsung hero, silently carrying out over 500 vital functions, from detoxifying the body to aiding in digestion and metabolism. Despite its critical role, liver health is often overlooked. Shockingly, 1.5 billion people battled chronic liver disease worldwide in 2017, resulting in 2 million lives lost annually. This World Liver Day, let's raise awareness, prioritize liver health, and work towards a healthier future for all. #WorldLiverDay #LiverHealthMatters #ClinicalResearch
-
-
Nadege Gunn, MD, CPI, Principal Investigator, and Jonatan Garcia, MPH, Community Liaison at Velocity Clinical Research in Waco, TX, welcomed many leaders from our team to the semi-annual MASH Bash — a gathering of community providers and partners for a liver education program, great food, and great conversations. More to come on this celebration next week!